Press Releases 2021

The identification of the source of infection is usually essential for successful outbreak control. If the infection source is not identified quickly, such outbreaks can go on for long periods of time and across different locations, making the identification of the causative agent very difficult.

However - how do you recognize that the pathogens involved are "similar"? What does "similar” mean, and how can we identify whether a pathogen has already been observed elsewhere or earlier? How exactly can pathogens be traced? For this, a detailed "fingerprint" of the pathogen is needed which identifies or excludes any similarities.

"In order to improve infection control, molecular surveillance of infectious agents is essential", says Professor L. H. Wieler, President and Head of the Robert Koch Institute. To provide suitable instruments a consortium has been initiated by partners from three German organizations: the University of Münster, the Research Center Borstel and the Robert Koch Institute to form the network "miGenomeSurv" (microbial genome-based surveillance of infectious agents). This network is based on national reference laboratories, where - according to their mandate - infectious agents relevant to the population are characterized not just microbiologically but also via genome analysis. Genome sequencing methods provide "fingerprints" and other characteristics of the bacteria allowing surveillance and cluster detection.

In the context of "miGenomeSurv", a common language (nomenclature) is defined for the numerous lineages of detected pathogens. "Easy-to-use bioinformatic tools help to give each pathogen a unique signature", explains Professor Dag Harmsen of the University of Münster. This particularly important aspect is based on the genome sequence and of a so-called core genome (cg) –MLST type calculated from the genome data. As a result, the genetic material of the pathogen is translated into a standardized numerical code. This allows an easy exchange of data between the participating laboratories, with other national and international partners and institutions such as the ECDC and the public health service responsible for implementing measures such as outbreak management. The genomic profiles and other project data are published in a summarized form on the network’s website at www.miGenomeSurv.org.

The consortium will first concentrate on the following high-priority organisms:

  • enterohaemorrhagic Escherichia coli (EHEC)
  • Listeria monocytogenes
  • multi-resistant Mycobacterium tuberculosis, M. bovis / caprae
  • Vancomycin-resistant enterococci (VRE).

"At the Research Center Borstel, the focus is on the transmission analysis of multidrug-resistant tuberculosis bacteria" says Professor S. Niemann, Director of the Program Area Infections at the Research Center Borstel. Due to the difficult and long treatment, tracing pathways is of particular importance for improving infection control of multidrug-resistant tuberculosis bacteria.

Contact:

Prof. Dr. Stefan Niemann
Prof. Dr. Stefan Niemann
04537 / 188-7620
04537 / 188-2091
This email address is being protected from spambots. You need JavaScript enabled to view it.

Prof. Dr. med. Florian Maurer
Prof. Dr. med. Florian Maurer
04537 / 188-2110
04537 / 188-3110
This email address is being protected from spambots. You need JavaScript enabled to view it.